Online Education | Hepatitis C Online | State of the Art Therapy for HCV

This module includes a review of all FDA-approved agents used to treat hepatitis C, including newer FDA-approved direct acting agents. The content will address the virologic responses to therapy, recommended therapy for treatment-naïve and treatment experienced patients, and monitoring and management of treatment-related adverse effects.

Target Audience

Primary care physicians, advanced registered nurse practitioners, physician assistants, hospitalizes, infectious disease specialists, gastroenterologists and hepatologists

Objectives for Learning Outcomes

After completing this course, you will be better able to:

  • Discuss the rapidly changing treatment landscape for hepatic C. 
  • List 3 medications not yet FDA-approved that show promise for treating genotype 1 HCV. 

Additional Information

Course summary
Maximum credit available: 
  • 0.75 Contact hours

Robert G. Gish, MD
Senior Medical Director, St Josephs Hospital and Medical Center Liver Program, Phoenix, Arizona
Clinical Professor of Medicine, University of Nevada, Las Vegas

Available Credit

  • 0.75 Contact hours
Please login or create account to take this course.